3 Stocks That May Be Priced Below Their Estimated Worth In June 2026 Simply Wall St. · 2026-06-03T11:38:08Z
Getting Alzheimer’s Drugs Into the Brain Is Hard. Now There’s a New Trick. Barrons.com · 2026-06-03T07:30:00Z
Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic Motley Fool · 2026-06-02T18:50:00Z
Intapp And 2 Additional Stocks That May Be Priced Below Estimated Value Simply Wall St. · 2026-06-02T17:38:21Z
AbbVie Inc. (ABBV) Announces EC Authorization of Expanded Label for VENCLYXTO® Insider Monkey · 2026-06-02T14:42:35Z
The S&P 500 Is Expensive, but These 3 Dividend Stocks Still Look Like Bargains Motley Fool · 2026-06-02T14:05:00Z
Is AbbVie Inc. (ABBV) Expanding Its Oncology Pipeline With New BPDCN Treatment Approval? Insider Monkey · 2026-06-02T13:55:13Z
3 Stocks Estimated To Be Trading Up To 49.6% Below Their Intrinsic Value Simply Wall St. · 2026-06-02T11:38:17Z